Suppr超能文献

一项针对帕金森病患者食物成瘾的病例对照研究。

A case-control study investigating food addiction in Parkinson patients.

机构信息

Service de Psychiatrie B, CHU Clermont-Ferrand, EA7280, Université Clermont Auvergne, Rue Montalembert BP 69, 63003, Clermont-Ferrand, France.

Service de Neurologie A, CHU Clermont-Ferrand, EA7280, Université Clermont Auvergne, Clermont-Ferrand, France.

出版信息

Sci Rep. 2021 May 25;11(1):10934. doi: 10.1038/s41598-021-90266-8.

Abstract

Eating disorders (EDs) in patients with Parkinson's disease (PD) are mainly described through impulse control disorders but represent one end of the spectrum of food addiction (FA). Although not formally recognized by DSM-5, FA is well described in the literature on animal models and humans, but data on prevalence and risk factors compared with healthy controls (HCs) are lacking. We conducted a cross-sectional study including 200 patients with PD and 200 age- and gender-matched HCs. Characteristics including clinical data (features of PD/current medication) were collected. FA was rated using DSM-5 criteria and the Questionnaire on Eating and Weight Patterns-Revised (QEWP-R). Patients with PD had more EDs compared to HCs (27.0% vs. 13.0%, respectively, p < 0.001). They mainly had FA (24.5% vs. 12.0%, p = 0.001) and night eating syndrome (7.0% vs. 2.5% p = 0.03). In PD patients, FA was associated with female gender (p = 0.04) and impulsivity (higher attentional non-planning factor) but not with the dose or class of dopaminergic therapy. Vigilance is necessary, especially for PD women and in patients with specific impulsive personality traits. Counterintuitively, agonist dopaminergic treatment should not be used as an indication for screening FA in patients with PD.

摘要

帕金森病 (PD) 患者的饮食障碍 (EDs) 主要通过冲动控制障碍来描述,但它们代表了食物成瘾 (FA) 的一个极端。尽管 FA 尚未被 DSM-5 正式认可,但在动物模型和人类文献中对其有很好的描述,但与健康对照组 (HCs) 相比,FA 的患病率和风险因素的数据尚缺乏。我们进行了一项横断面研究,纳入了 200 名 PD 患者和 200 名年龄和性别匹配的 HCs。收集了包括临床数据(PD 特征/当前用药)在内的特征。使用 DSM-5 标准和饮食和体重模式问卷修订版 (QEWP-R) 对 FA 进行评估。与 HCs 相比,PD 患者的 EDs 更多(分别为 27.0%和 13.0%,p<0.001)。他们主要患有 FA(24.5%和 12.0%,p=0.001)和夜间进食综合征(7.0%和 2.5%,p=0.03)。在 PD 患者中,FA 与女性性别(p=0.04)和冲动性(更高的注意力非计划因素)相关,但与多巴胺能治疗的剂量或类型无关。需要保持警惕,尤其是对 PD 女性和具有特定冲动人格特征的患者。具有讽刺意味的是,激动剂多巴胺能治疗不应作为 PD 患者筛查 FA 的指征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80dc/8149641/a8a395e95747/41598_2021_90266_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验